Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605449 · ClinicalTrials.gov registry record · Phase 1
A Drug Interaction Study Between Simvastatin and GSK376501
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT00605449 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 39 participants.
The verdict
NCT00605449, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This study is a 3-period crossover drug interaction study between GSK376501 and simvastatin in healthy adult subjects. This study will examine if repeat doses of GSK376501 affects the pharmacokinetics of simvastatin and if repeat doses of simvastatin affects the pharmacokinetics of GSK375601.
Interventions
- DRUG GSK376501
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00605449
The ClinicalTrials.gov registry entry for NCT00605449 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK376501 is the first listed.
NCT00605449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00605449 about?
NCT00605449 is a clinical study titled "A Drug Interaction Study Between Simvastatin and GSK376501". This study is a 3-period crossover drug interaction study between GSK376501 and simvastatin in healthy adult subjects. This study will examine if repeat doses of GSK376501 affects the pharmacokinetics of simvastatin and if repeat doses of simvastatin affects the pharmacokinetics of GSK375601.
What is the current status of trial NCT00605449?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2008-01. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00605449?
The interventions under investigation include: GSK376501 (DRUG).
Who is sponsoring clinical trial NCT00605449?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.